Evidence map›Paper›PMID 32110367›Full record

ArticleChemical science2020

Datasets and their influence on the development of computer assisted synthesis planning tools in the pharmaceutical domain.

Amol Thakkar, Thierry Kogej, Jean-Louis Reymond, Ola Engkvist, Esben Jannik Bjerrum

Abstract read
In one paragraph

Article in Chemical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. AI-Based Retrosynthesis of Known and Unexplored Covalent Organic Framework Monomers.Chemistry of materials : a publication of the American Chemical Society · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Identification of nanomolar adenosine ANature communications · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Investigations into the Efficiency of Computer-Aided Synthesis Planning.Journal of chemical information and modeling · 2025
    Article
  14. Article
  15. Application of Transformers to Chemical Synthesis.Molecules (Basel, Switzerland) · 2025
    Review
  16. Article
  17. Article
  18. ORDerly: Data Sets and Benchmarks for Chemical Reaction Data.Journal of chemical information and modeling · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amol ThakkarHit Discovery , Discovery Sciences, R&D , AstraZeneca , Gothenburg , Sweden . Email: esben.bjerrum@astrazeneca.com.ORCID 0000-0003-0403-4067
Thierry KogejHit Discovery , Discovery Sciences, R&D , AstraZeneca , Gothenburg , Sweden . Email: esben.bjerrum@astrazeneca.com.
Jean-Louis ReymondDepartment of Chemistry and Biochemistry , University of Bern , Bern , Switzerland . Email: amol.thakkar@dcb.unibe.ch.ORCID 0000-0003-2724-2942
Ola EngkvistHit Discovery , Discovery Sciences, R&D , AstraZeneca , Gothenburg , Sweden . Email: esben.bjerrum@astrazeneca.com.
Esben Jannik BjerrumHit Discovery , Discovery Sciences, R&D , AstraZeneca , Gothenburg , Sweden . Email: esben.bjerrum@astrazeneca.com.ORCID 0000-0003-1614-7376

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Computer Assisted Synthesis Planning (CASP) has gained considerable interest as of late. Herein we investigate a template-based retrosynthetic planning tool, trained on a variety of datasets consisting of up to 17.5 million reactions. We demonstrate that models trained on datasets such as internal Electronic Laboratory Notebooks (ELN), and the publicly available United States Patent Office (USPTO) extracts, are sufficient for the prediction of full synthetic routes to compounds of interest in medicinal chemistry. As such we have assessed the models on 1731 compounds from 41 virtual libraries for which experimental results were known. Furthermore, we show that accuracy is a misleading metric for assessment of the policy network, and propose that the number of successfully applied templates, in conjunction with the overall ability to generate full synthetic routes be examined instead. To this end we found that the specificity of the templates comes at the cost of generalizability, and overall model performance. This is supplemented by a comparison of the underlying datasets and their corresponding models.

Identifiers

PMID32110367
PMCPMC7012039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.